Seeking Alpha

Inovio Pharmaceuticals EPS in-line, beats on revenue

  • Inovio Pharmaceuticals (NYSEMKT:INO): Q2 EPS of -$0.19 in-line.
  • Revenue of $3.8M (+387.2% Y/Y) beats by $2M.
  • Press Release
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: